Pharmaceutical Research Associates Denmark ApS

Private limited companyCVR 33242840HellerupActive

Pharmaceutical Research Associates Denmark ApS is a private limited company, based in Hellerup, active in research and experimental development on natural sciences and engineering, founded in 2010. Net profit fell 14% from 2024 to 2025, ending at DKK 3.1m. With 50 employees, the company is about 10 times larger than the industry median. Gross profit is higher than that of 94% of the companies in the industry in the database.

Follow
PDF reportCompare

Key figures · financial year 2025

Gross profitDKK 61.6m−14.7% vs. 2024
Net profitDKK 3.1m−14.1% vs. 2024
EquityDKK 23.9m+14.6% vs. 2024
Employees50latest month from CVR

What has changed

calculated from recorded figures and dates

Financials: 2025 against 2024

  • Gross profit fell 15% (2024 → 2025), to DKK 61.6m.
  • Net profit fell 14% (2024 → 2025), to DKK 3.1m.
  • Equity rose 15% (2024 → 2025), to DKK 23.9m.

Employees

  • 4 fewer employees than a year earlier: 50 (08/2026) against 54 (08/2025).

Registrations, last 24 months

  • 17/09/2026: Moved to Strandvejen 102B, 5. tv, 2900 Hellerup
  • 19/12/2025: Moved to H.C. Andersens Boulevard 48, 1, 1553 København V
  • 01/01/2025: Industry changed to Research and experimental development on natural sciences and engineering (721000)

Calculated from the latest two annual reports in sequence and from registrations in CVR. A figure that is missing in either year gives no line, and we derive no figures.

Financial statements

Financial years 2020–2025 · amounts in DKK thousand

Equity and net profit

DKK 0DKK 5mDKK 10mDKK 15mDKK 20mDKK 25m202020212022202320242025
EquityNet profit
Financial figures for Pharmaceutical Research Associates Denmark ApS
202020212022202320242025Change
Revenuenot statednot statednot statednot statednot statednot stated–
Gross profit34,74644,68657,09064,00272,28461,634−14.7%
Operating profit (EBIT)2,6223,9393,5244,0084,5103,893−13.7%
Profit before tax2,6373,8463,4934,0024,5633,930−13.9%
Net profit2,0573,0002,7233,1143,5543,054−14.1%
Total assets13,97117,63018,39839,03446,59247,334+1.6%
Equity8,50111,50114,22417,33820,89223,946+14.6%
Liabilities5,4706,1294,17421,69625,70023,388−9%
Cash and cash equivalents6085393,1951,5213,4652,415−30.3%
Average number of employees374757637258−19.4%

Source: annual reports filed with the Danish Business Authority (XBRL). Figures for the company (not the group); change is the latest year against the year before. “–” means the figure is not stated in the annual report. Revenue is not stated for 2020, 2021, 2022, 2023, 2024, 2025: smaller companies may omit it, and we do not derive it from other figures.

Download the figures as CSV · free with an account, amounts in whole DKK

DKK 0DKK 10mDKK 20mDKK 30mDKK 40mDKK 50mDKK 60mDKK 70m202020212022202320242025
Gross profitMedian, the industry (431 companies)

Signals from the financial statements

calculated from the 2025 figures
  • Profit for five years in a row

    Net result has been positive in 2021–2025.

    How is this calculated?

    Net result is positive in the five latest annual reports in a row.

The signals are rules applied to the figures in the annual reports. They are not an assessment or credit rating of the company. See Data and method.

Annual reports

6 financial years
Annual reports for Pharmaceutical Research Associates Denmark ApS
Financial yearPeriodPublishedFigures forDocuments
202501/01/2025 – 31/12/202507/07/2026The companyPDF not statedXBRL
202401/01/2024 – 31/12/202430/06/2025The companyPDFXBRL
202301/01/2023 – 31/12/202321/06/2024The companyPDFXBRL
202201/01/2022 – 31/12/202208/08/2023The companyPDFXBRL
202101/01/2021 – 31/12/202107/07/2022The companyPDFXBRL
202001/01/2020 – 31/12/202002/08/2021The companyPDFXBRL

The figures from all the annual reports are shown on this page. The documents themselves (PDF and XBRL, the machine-readable edition) are downloaded with a Pro account: sign in or create a free account, and then choose Pro. XBRL is the edition the figures on the page are read from.

Employees

monthly figures from CVR
0102030405060708009/2310/2311/2312/2301/2402/2403/2404/2405/2406/2407/2408/2409/2410/2411/2412/2401/2502/2503/2504/2505/2506/2507/2508/2509/2510/2511/2512/2501/2602/2603/2604/2605/2606/2607/2608/26
Employees

Position in the industry

431 companies in the database

Comparison with the other companies in research and experimental development on natural sciences and engineering based on the latest financial year.

Gross profitDKK 61.6mNo. 27 of 421
Better than 94% of the companies in the industry
EquityDKK 23.9mNo. 95 of 431
Better than 78% of the companies in the industry
Number of employees50No. 32 of 431
Better than 93% of the companies in the industry

Industry median: gross profit DKK 616k, net profit −DKK 892k, equity DKK 2m, 5 employees.

DKK 100kDKK 2.5mDKK 63.4mDKK 1.6bnDKK 13.7bnHere
Distribution of gross profit for 250 companies in the industry (latest financial year, logarithmic scale). Amber bar: where this company sits.

Compared with similar companies

size, age and company form
Rank among similar companies
GroupGross profitEquity
Companies with 50–199 employees4,467 companies in the comparison
No. 1,376of 4,412
Better than 69%
No. 1,989of 4,466
Better than 55%
Same industry and 50–199 employees27 companies in the comparison
No. 13of 26
Better than 52%
No. 20of 27
Better than 27%
Companies that are between 15 and 29 years old24,910 companies in the comparison
No. 1,162of 24,791
Better than 95%
No. 3,961of 24,909
Better than 84%
All companies of type ApS66,508 companies in the comparison
No. 557of 66,379
Better than 99%
No. 3,724of 66,505
Better than 94%

The rank is calculated among companies in the database with a figure for the latest financial year, and is shown only for groups of at least ten companies.

Compare with the industry

Research and experimental development on natural sciences and engineering
Gross profit
  1. Pharmaceutical Research Associates Denmark ApSDKK 61.6m
  2. Carlsberg A/SDKK 40.2bn
  3. Zealand Pharma A/SDKK 9.2bn
Net profit
  1. Pharmaceutical Research Associates Denmark ApSDKK 3.1m
  2. Carlsberg A/SDKK 7bn
  3. Zealand Pharma A/SDKK 6.5bn
Equity
  1. Pharmaceutical Research Associates Denmark ApSDKK 23.9m
  2. Carlsberg A/SDKK 30.7bn
  3. Zealand Pharma A/SDKK 14.8bn
Employees
  1. Pharmaceutical Research Associates Denmark ApS50
  2. Carlsberg A/S107
  3. Zealand Pharma A/S569

Latest financial year per company. Choose up to three companies from the largest in the industry.

Owners and group

from the Public Ownership Register
Owners
  • Icon Clinical (uk) Limited100%
Pharmaceutical Research Associates Denmark ApS

Management

4 active registrations

Executive management

Executive management at Pharmaceutical Research Associates Denmark ApS
NameRoleAppointed
Thomas Noel O´LearyDirector15/12/2023

Board of directors

Board of directors at Pharmaceutical Research Associates Denmark ApS
NameRoleAppointed
Simon Peter HollywoodBoard member01/07/2021
John SheahanBoard member01/07/2021
Thomas Noel O´LearyChair of the board15/12/2023
Founders
Pharm Research Associates (UK) Limited
Former management (7)
Former management at Pharmaceutical Research Associates Denmark ApS
NameRoleAppointedResigned
Colin ShannonBoard member07/10/201001/07/2021
Colin ShannonDirector07/10/201001/07/2021
Christopher John GrayBoard member07/10/201001/07/2021
Susan Caroline StansfieldChair of the board07/10/201012/10/2011
Timothy Jon McClainChair of the board12/10/201104/10/2018
Robert James LeftwichChair of the board04/10/201815/12/2023
Robert James LeftwichDirector01/07/202115/12/2023

Signing rule: Selskabet tegnes af bestyrelsesmedlemmerne i forening eller af et medlem af bestyrelsen eller en direktør hver for sig.

Address and production units

1 active production units

Strandvejen 102B
2900 Hellerup

Gentofte Municipality · Postcode 2900

Other companies at the address (3)

Production units
Production unitAddressEmployeesP number
PHARMACEUTICAL RESEARCH ASSOCIATES DENMARK ApSStrandvejen 102B, 5. tv, 2900 Hellerup501016364734

Purpose

Selskabets formål er at udføre generel klinisk forskning og hermed forbundet virksomhed efter bestyrelsens skøn.

The purpose is quoted from the register in Danish.

Changes year by year

33 registered events
20262 changesaddress 1 · accounts 1
  • Moved to Strandvejen 102B, 5. tv, 2900 Hellerup
  • Annual report for 2025 published
20253 changesaddress 1 · accounts 1 · industry 1
  • Moved to H.C. Andersens Boulevard 48, 1, 1553 København V
  • Annual report for 2024 published
  • Industry changed to Research and experimental development on natural sciences and engineering (721000)
20241 changeaccounts 1
  • Annual report for 2023 published
20236 changesmanagement 4 · address 1 · accounts 1
  • Thomas Noel O´Leary appointed director
  • Thomas Noel O´Leary appointed chair of the board
  • Robert James Leftwich stepped down as director
  • Robert James Leftwich stepped down as chair of the board
  • Moved to Sankt Ols Gade 4, 4000 Roskilde
  • Annual report for 2022 published
20221 changeaccounts 1
  • Annual report for 2021 published
20217 changesaccounts 1 · management 6
  • Annual report for 2020 published
  • Robert James Leftwich appointed director
  • John Sheahan appointed board member
  • Simon Peter Hollywood appointed board member
  • Colin Shannon stepped down as board member
  • Christopher John Gray stepped down as board member
  • Colin Shannon stepped down as director
20182 changesmanagement 2
  • Robert James Leftwich appointed chair of the board
  • Timothy Jon McClain stepped down as chair of the board
20114 changesmanagement 2 · address 1 · industry 1
  • Timothy Jon McClain appointed chair of the board
  • Susan Caroline Stansfield stepped down as chair of the board
  • Moved to Havneholmen 29, 1561 København V
  • Industry changed to Forskning og eksperimentel udvikling indenfor bioteknologi (721100)
20107 changesaddress 1 · founded 1 · management 4 · ownership 1
  • Moved to Lautrupsgade 7, 2100 København Ø
  • Registered as PHARMACEUTICAL RESEARCH ASSOCIATES DENMARK ApS
  • Colin Shannon appointed board member
  • Susan Caroline Stansfield appointed chair of the board
  • Christopher John Gray appointed board member
  • Colin Shannon appointed director
  • ICON CLINICAL (UK) LIMITED registered as owner (100%)

Related companies

Largest in the industry

See all →

Source and updates

The information comes from the Danish Central Business Register (Danish Business Authority) and from annual reports filed with the Danish Business Authority. Last synchronised 24/10/2026. The company is protected against advertising; contact details are not shown, and the data must not be used for marketing.

View in CVRReport a correction